News

MMS Holdings Launches New Time-Saving Application to Automatically Perform Quality Control and Style Checks for Medical Writers

MMS Holdings Launches New Time-Saving Application to Automatically Perform Quality Control and Style Checks for Medical Writers
Automatiqc®, an AI tool designed to improve quality and bring efficiencies to the medical and regulatory writing process

Automatiqc®

automation solutions for regulatory and medical writingAutomatiqc® is a cloud-based solution that utilizes robotic process automation (RPA), a form of artificial intelligence (AI), to apply the necessary document formatting and style conventions. This frees up writers to focus on the key messaging, stakeholder alignment, and other key elements that are most critical to the medical and regulatory writing process.   

Demonstrated time savings have provided sponsors up to one-third (33 percent) of time back in the quality process, with efficiencies across several roles.  

Additional key benefits of Automatiqc® include: 

  • Removes the burden of style and formatting from the regulatory or medical writer, saving time for critical data elements  
  • Built-in set of rules that can be customized to meet any internal company or external audience document style requirements 
  • Compounding efficiencies with document amendments, improving the quality of documents and elimination of the review and QC steps in subsequent drafts or document amendments 
  • Complementary and compatible with other tools including PleaseReview, Veeva RIM, and many others 
  • Easy output provided in tracked changes for greater visibility to the writer  

With this innovative medical writing technology, Automatiqc® users are now able to focus where they can bring the greatest value – to the science of Medical & Regulatory Writing.  

Fill out the form at right to request a demo of Automatiqc®

Find out more about our commitment to innovation and tech-enablement here

Authoring Efficiencies Webinar

expert insights

rare diseases drug development draft guidance US Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, and other global health authorities service provider vendor services cro consultant clinical research organization mms holdings orphan regulations regulatory submissions medical writing QC as a service automatiqc

Medical writing experts discuss recent technological advancements, writing efficiencies, and a top-to-bottom integration approach across key stakeholders to produce high-quality CSRs that are FDA/EMA submission- and clinical trial disclosure-ready.

Watch the webinar

Request a demo of Automatiqc®